All Stories

  1. Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs)

    Article • SpringerPlus, August 2015, Springer Science + Business Media

    Hugo van der Kuy

  2. The value of computer assisted medication review in hospitalised patients

    Article • Clinical Therapeutics, August 2015, Elsevier

    Hugo van der Kuy

  3. No advantage of adrenaline in the local infiltration analgesia mixture during total knee arthroplasty

    Article • Knee Surgery Sports Traumatology Arthroscopy, July 2015, Springer Science + Business Media

    Hugo van der Kuy

  4. Evaluation of clinical rules in a standalone pharmacy based clinical decision support system for hospitalized and nursing home patients

    Article • International Journal of Medical Informatics, June 2015, Elsevier

    Dr Bjorn Winkens, Hugo van der Kuy

  5. The first study published?

    Article • Annals of Oncology, May 2015, Oxford University Press (OUP)

    Hugo van der Kuy

  6. To what extent is clinical and laboratory information used to perform medication reviews in the nursing home setting? the CLEAR study

    Article • Therapeutics and Clinical Risk Management, May 2015, Dove Medical Press

    Dr Bjorn Winkens, Hugo van der Kuy

  7. Usually available clinical and laboratory data are insufficient for a valid medication review: a crossover study

    Article • The journal of nutrition health & aging, April 2015, Springer Science + Business Media

    Dr Bjorn Winkens, Hugo van der Kuy

  8. Clinical practice of medication reviews in institutional care settings for older people in the Netherlands: an explorative survey

    Article • European Journal of Hospital Pharmacy, December 2014, BMJ

    Dr Bjorn Winkens, Hugo van der Kuy

  9. PS-062 To what extent is information used to perform medicines review?

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Hugo van der Kuy

  10. PS-061 Developing and optimising a clinical decision support system

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Hugo van der Kuy

  11. PS-101 The development and optimisation of a clinical rule

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Hugo van der Kuy

  12. PS-011 Evaluation of clinical rules in a clinical decision support system for hospitalised and nursing home patients

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Hugo van der Kuy

  13. A fully automated medication review?

    Article • International Journal of Clinical Pharmacy, November 2013, Springer Science + Business Media

    Hugo van der Kuy

  14. Medication reviews in elderly patients: Substantial variation in daily practice

    Article • European Geriatric Medicine, September 2013, Elsevier

    Hugo van der Kuy

  15. Development of a computer system to support medication reviews in nursing homes

    Article • International Journal of Clinical Pharmacy, July 2013, Springer Science + Business Media

    Hugo van der Kuy

  16. Covariates that influence the quality of a medication review

    Article • European Journal of Hospital Pharmacy, July 2013, BMJ

    Hugo van der Kuy

  17. Current situation for medication process and pharmacovigilance in The Netherlands: a comparison between cytostatic and non-cytostatic agents

    Article • European Journal of Hospital Pharmacy, July 2013, BMJ

    Hugo van der Kuy

  18. Medication surveillance on intravenous cytotoxic agents: a retrospective study

    Article • International Journal of Clinical Pharmacy, April 2013, Springer Science + Business Media

    Hugo van der Kuy

  19. Wat weten de patiënt en zijn hulpverlener: de meerwaarde van een huisbezoek door de praktijkondersteuner bij de medicatiebeoordelingen van patiënten met polyfarmacie in de eerste lijn

    Article • Tijdschrift voor Gerontologie en Geriatrie, March 2013, Springer Science + Business Media

    Hugo van der Kuy

  20. PHC-011 Dual Absorption in Intranasal Administration: A New Pharmacokinetic Model

    Article • European Journal of Hospital Pharmacy, March 2013, BMJ

    Hugo van der Kuy

  21. Patient Satisfaction with Intranasal Fentanyl for Breakthrough Pain

    Article • Journal of Palliative Medicine, June 2012, Mary Ann Liebert Inc

    Hugo van der Kuy

  22. Determining the feasibility of objective adherence measurement with blister packaging smart technology

    Article • American Journal of Health-System Pharmacy, May 2012, American Society of Health System Pharmacists

    Hugo van der Kuy

  23. Electronic Monitoring of Adherence, Treatment of Hypertension, and Blood Pressure Control

    Article • American Journal of Hypertension, January 2012, Oxford University Press (OUP)

    Hugo van der Kuy

  24. Pharmacokinetics and Tolerability of Nasal Versus Intravenous Midazolam in Healthy Dutch Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Pilot Study

    Article • Clinical Therapeutics, December 2011, Elsevier

    Hugo van der Kuy

  25. Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment: A Retrospective Cohort Study

    Article • Hypertension, August 2011, Wolters Kluwer Health

    Hugo van der Kuy

  26. Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports

    Article • International Journal of Clinical Pharmacology and Therapeutics, January 2011, Dustri-Verlgag Dr. Karl Feistle

    Hugo van der Kuy

  27. Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled ...

    Article • Clinical Therapeutics, July 2010, Elsevier

    Hugo van der Kuy

  28. A double blind randomised study of intranasal fentanyl versus placebo in patients undergoing removal of drains after mamma surgery

    Article • European Journal of Anaesthesiology, June 2010, Wolters Kluwer Health

    Hugo van der Kuy

  29. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension

    Article • Journal of Hypertension, March 2010, Wolters Kluwer Health

    Hugo van der Kuy

  30. Assessing Medication Adherence Simultaneously by Electronic Monitoring and Pill Count in Patients With Mild-to-Moderate Hypertension

    Article • American Journal of Hypertension, February 2010, Oxford University Press (OUP)

    Hugo van der Kuy

  31. A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally

    Article • Clinical Therapeutics, December 2009, Elsevier

    Hugo van der Kuy

  32. Factors influencing bar-code verification by nurses during medication administration in a Dutch hospital

    Article • American Journal of Health-System Pharmacy, April 2008, American Society of Health System Pharmacists

    Hugo van der Kuy

  33. Hoe doorslaggevend is ISA bij de keuze van een bètablokker bij mensen met astma die toch een bètablokker nodig hebben?

    Article • January 2008, Springer Science + Business Media

    Hugo van der Kuy

  34. Self-Measurement of Blood Pressure at Home Reduces the Need for Antihypertensive Drugs: A Randomized, Controlled Trial

    Article • Hypertension, October 2007, Wolters Kluwer Health

    Hugo van der Kuy

  35. Triptans in the treatment of migraine: drug selection by means of the SOJA method

    Article • Expert Opinion on Pharmacotherapy, October 2007, Informa Healthcare

    Hugo van der Kuy

  36. Pharmacokinetic Interaction between Nortriptyline and Terbinafine

    Article • Annals of Pharmacotherapy, November 2002, SAGE Publications

    Hugo van der Kuy

  37. Pharmacokinetic Interaction Between Nortriptyline and Terbinafine

    Article • Annals of Pharmacotherapy, November 2002, SAGE Publications

    Hugo van der Kuy

  38. Hydroxocobalamin, A Nitric Oxide Scavenger, in the Prophylaxis of Migraine: an Open, Pilot Study

    Article • Cephalalgia, September 2002, SAGE Publications

    Hugo van der Kuy

  39. A Quantification of the Placebo Response in Migraine Prophylaxis

    Article • Cephalalgia, May 2002, SAGE Publications

    Hugo van der Kuy

  40. Bioavailability of intranasal formulations of dihydroergotamine

    Article • European Journal of Clinical Pharmacology, November 1999, Springer Science + Business Media

    Hugo van der Kuy

  41. Efficacy and Safety of Cyclodextrins in Nasal Drug Delivery

    Article • January 1999, Springer Science + Business Media

    Hugo van der Kuy

  42. A triptan too far?

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 1999, BMJ

    Hugo van der Kuy